
TG Therapeutics, Inc.
USD55.95
+0.23 (+0.41%)
CEO
Michael S. Weiss
IPO Date
2010-05-03
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$55.89
Prev. Close
$55.72
Day Low
$54.50
Day High
$56.20
52W Low
$25.28
52W High
$57.38
Market Cap
$8.57B
Volume
0.47M
TG Therapeutics Announces Presentation of Data from the ULTIMATE I & II Phase 3 Trials of Ublituximab in Multiple Sclerosis at 7th Congress of the European Academy of Neurology